allitinib,
AST 1306,
AST-1306,
AST1306,
N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-6-quinazolinyl)acrylamide,
1050500-29-2,
AST-1306 TsOH,
Allitinib tosylate,
AST-6,
AST-1306 (TsOH),
AST-1306 p-Toluenesulfonic Acid,
AST 1306,
N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide 4-methylbenzenesulfonate,
N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)acrylamide 4-methylbenzenesulfonate,
AST 1306 tosylate,
AST1306 TsOH,
Allitinib (AST-1306),
MLS006011282,
SCHEMBL230864,
AST-6/,
DTXSID30648510,
HMS3655D08,
BCP02099,
EX-A2292,
ABP000605,
s2185,
AKOS027288723,
CS-1209,
RL00237,
AC-28450,
HY-13427,
SC-94601,
SMR004703032,
B1020,
FT-0741105,
SW219180-1,
A10062,
W-5685,
J-001339,
J-523338,
4-Methylbenzene-1-sulfonic acid--N-(4-{3-chloro-4-[(3-fluorophenyl)methoxy]anilino}quinazolin-6-yl)prop-2-enamide (1/1),
N-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)acrylamide 4-methylbenzenesulfonate,
AST-1306,
cc-284,
ZMUKJEHWLJBODV-UHFFFAOYSA-N,
897383-62-9,